Agenda Topics- Biomarker Classes: Genomics-based, Proteomics-based, Metabolomics-based
- Discovery & Validation Technologies
- Gene Signatures for Breast and Colon Cancers: Drivers of Innovation in this Field
- Predictive vs. Prognostic Biomarkers
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Distinguished FacultyJason Bielas, Assistant Member, Fred Hutchinson Cancer Research Center Darius Dziuda, Associate Professor, Central Connecticut State University Spiros Garbis, Associate Professor/Head, University of Southampton William Gallaghr, Chief Scientific Officer/Professor, OncoMark Limited/University College Dublin Gary Coulton, Director, St Georges University of London John Timms, Group Leader, University College London Christoph Turck, Head, Max Planck Institute of Psychiatry Enal Razvi, Managing Director, Select Biosciences Inc Niklas Mattsson, Medical Doctor & Researcher, Sahlgrens University Hospital Salvatore Pernagallo, Product Development Manager, DestiNA Genomics Ltd Paul Tempst, Professor, Memorial Sloan-Kettering Cancer Center Kay Ohlendieck, Professor, National University of Ireland Cristiana Tanase, Proteomics Group Leader, "Victor Babes" National Institute of Pathology Saskia Vosslamber, Researcher, VU University Medical Center Richard Morgan, Senior Lecturer, University of Surrey Hazel Pinheiro, Senior Scientist, Exiqon
|